LUM-015 shows potential for imaging of inflammatory protease activity in atherosclerosis April 5, 2022
Redox-tuned [18F]4FN radiopharmaceutical is useful for imaging innate immunity activation Feb. 25, 2022
New PET ligand allows in vivo pharmacological evaluation of agents targeting mutant HTT expression Feb. 9, 2022
Navidea sponsors research at Penn to evaluate Tc99m tilmanocept as prognostic marker in glioblastoma Feb. 8, 2022
RSS